208 related articles for article (PubMed ID: 29326123)
1. Tumor necrosis factor receptor signaling is a driver of chronic lymphocytic leukemia that can be therapeutically targeted by the flavonoid wogonin.
Dürr C; Hanna BS; Schulz A; Lucas F; Zucknick M; Benner A; Clear A; Ohl S; Öztürk S; Zenz T; Stilgenbauer S; Li-Weber M; Krammer PH; Gribben JG; Lichter P; Seiffert M
Haematologica; 2018 Apr; 103(4):688-697. PubMed ID: 29326123
[TBL] [Abstract][Full Text] [Related]
2. A protein disulfide isomerase/thioredoxin-1 complex is physically attached to exofacial membrane tumor necrosis factor receptors: overexpression in chronic lymphocytic leukemia cells.
Söderberg A; Hossain A; Rosén A
Antioxid Redox Signal; 2013 Feb; 18(4):363-75. PubMed ID: 22775451
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory cytokines and signaling pathways are associated with survival of primary chronic lymphocytic leukemia cells in vitro: a dominant role of CCL2.
Schulz A; Toedt G; Zenz T; Stilgenbauer S; Lichter P; Seiffert M
Haematologica; 2011 Mar; 96(3):408-16. PubMed ID: 21134984
[TBL] [Abstract][Full Text] [Related]
4. Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia.
Fiorcari S; Martinelli S; Bulgarelli J; Audrito V; Zucchini P; Colaci E; Potenza L; Narni F; Luppi M; Deaglio S; Marasca R; Maffei R
Haematologica; 2015 Feb; 100(2):253-62. PubMed ID: 25398834
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of BCR signaling using the Syk inhibitor TAK-659 prevents stroma-mediated signaling in chronic lymphocytic leukemia cells.
Purroy N; Carabia J; Abrisqueta P; Egia L; Aguiló M; Carpio C; Palacio C; Crespo M; Bosch F
Oncotarget; 2017 Jan; 8(1):742-756. PubMed ID: 27888629
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.
Larsson LG; Carlsson M; Schena M; Lantz M; Caligaris-Cappio F; Nilsson K
Leukemia; 1993 Feb; 7(2):226-34. PubMed ID: 8381194
[TBL] [Abstract][Full Text] [Related]
7. Survival and Immunosuppression Induced by Hepatocyte Growth Factor in Chronic Lymphocytic Leukemia.
Giannoni P; Cutrona G; Totero D
Curr Mol Med; 2017; 17(1):24-33. PubMed ID: 28231754
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia.
Cavallini C; Lovato O; Bertolaso A; Zoratti E; Malpeli G; Mimiola E; Tinelli M; Aprili F; Tecchio C; Perbellini O; Scarpa A; Zamò A; Cassatella MA; Pizzolo G; Scupoli MT
Oncotarget; 2015 Oct; 6(31):32061-74. PubMed ID: 26393680
[TBL] [Abstract][Full Text] [Related]
9. p66Shc deficiency in the Eμ-TCL1 mouse model of chronic lymphocytic leukemia enhances leukemogenesis by altering the chemokine receptor landscape.
Patrussi L; Capitani N; Ulivieri C; Manganaro N; Granai M; Cattaneo F; Kabanova A; Mundo L; Gobessi S; Frezzato F; Visentin A; Finetti F; Pelicci PG; D'Elios MM; Trentin L; Semenzato G; Leoncini L; Efremov DG; Baldari CT
Haematologica; 2019 Oct; 104(10):2040-2052. PubMed ID: 30819907
[TBL] [Abstract][Full Text] [Related]
10. NF-κB activation in chronic lymphocytic leukemia: A point of convergence of external triggers and intrinsic lesions.
Mansouri L; Papakonstantinou N; Ntoufa S; Stamatopoulos K; Rosenquist R
Semin Cancer Biol; 2016 Aug; 39():40-8. PubMed ID: 27491692
[TBL] [Abstract][Full Text] [Related]
11. Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.
Secchiero P; Corallini F; Barbarotto E; Melloni E; di Iasio MG; Tiribelli M; Zauli G
J Cell Physiol; 2006 Apr; 207(1):158-64. PubMed ID: 16270354
[TBL] [Abstract][Full Text] [Related]
12. Regulation of MAPK signaling and implications in chronic lymphocytic leukemia.
Shukla A; Shukla V; Joshi SS
Leuk Lymphoma; 2018 Jul; 59(7):1565-1573. PubMed ID: 28882083
[TBL] [Abstract][Full Text] [Related]
13. Access to follicular dendritic cells is a pivotal step in murine chronic lymphocytic leukemia B-cell activation and proliferation.
Heinig K; Gätjen M; Grau M; Stache V; Anagnostopoulos I; Gerlach K; Niesner RA; Cseresnyes Z; Hauser AE; Lenz P; Hehlgans T; Brink R; Westermann J; Dörken B; Lipp M; Lenz G; Rehm A; Höpken UE
Cancer Discov; 2014 Dec; 4(12):1448-65. PubMed ID: 25252690
[TBL] [Abstract][Full Text] [Related]
14. SLP76 integrates into the B-cell receptor signaling cascade in chronic lymphocytic leukemia cells and is associated with an aggressive disease course.
Dezorella N; Katz BZ; Shapiro M; Polliack A; Perry C; Herishanu Y
Haematologica; 2016 Dec; 101(12):1553-1562. PubMed ID: 27443285
[TBL] [Abstract][Full Text] [Related]
15. TNF receptors in chronic lymphocytic leukemia.
Waage A; Espevik T
Leuk Lymphoma; 1994 Mar; 13(1-2):41-6. PubMed ID: 8025522
[TBL] [Abstract][Full Text] [Related]
16. Modeling the chronic lymphocytic leukemia microenvironment in vitro.
Crassini K; Shen Y; Mulligan S; Giles Best O
Leuk Lymphoma; 2017 Feb; 58(2):266-279. PubMed ID: 27756161
[TBL] [Abstract][Full Text] [Related]
17. Targeting Macrophages Sensitizes Chronic Lymphocytic Leukemia to Apoptosis and Inhibits Disease Progression.
Galletti G; Scielzo C; Barbaglio F; Rodriguez TV; Riba M; Lazarevic D; Cittaro D; Simonetti G; Ranghetti P; Scarfò L; Ponzoni M; Rocchi M; Corti A; Anselmo A; van Rooijen N; Klein C; Ries CH; Ghia P; De Palma M; Caligaris-Cappio F; Bertilaccio MTS
Cell Rep; 2016 Feb; 14(7):1748-1760. PubMed ID: 26876171
[TBL] [Abstract][Full Text] [Related]
18. Of Lymph Nodes and CLL Cells: Deciphering the Role of CCR7 in the Pathogenesis of CLL and Understanding Its Potential as Therapeutic Target.
Cuesta-Mateos C; Brown JR; Terrón F; Muñoz-Calleja C
Front Immunol; 2021; 12():662866. PubMed ID: 33841445
[TBL] [Abstract][Full Text] [Related]
19. Chronic lymphocytic leukaemia--the role of the microenvironment pathogenesis and therapy.
Ramsay AD; Rodriguez-Justo M
Br J Haematol; 2013 Jul; 162(1):15-24. PubMed ID: 23617880
[TBL] [Abstract][Full Text] [Related]
20. TNF family molecules in the serum of patients with B-cell chronic lymphocytic leukemia (B-CLL).
Jablonska E; Kiersnowska-Rogowska B; Rogowski F; Parfienczyk A; Puzewska W; Bukin M
Leuk Lymphoma; 2005 Sep; 46(9):1307-12. PubMed ID: 16109608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]